XTL Biopharmaceuticals Ltd.

Regulatory Filings • Apr 1, 2015

_________ false

C003��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: -11996381Medinat hayehudim st 85 , Herzliya 4614001 , ,Tel: 09-9557080 begin_of_the_skype_highlighting 09-9557080 FREE end_of_the_skype_highlighting , Fax: 09-9519727E.mail address: ir@xtlbio.comReported via MAGNA: 01/04/2015              Time of broadcast: 10:13 10:12:10

Company site:		www.xtlbio.com

Reference: 2015-02-071230

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	XTL Biopharmaceuticals Announces Pricing of $4.0 Million Registered Direct Offering

XTL_6K_re_Pricing_310315_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 09/03/2015
- - -
Name of the Signatory: : Kntor Ronen , Position of Signatory in the reporting corporation: Legal Adviser , Name of Employer Company: .
Abba Hillel Silver Rd Telephone: 03-6133371 begin_of_the_skype_highlighting 03-6133371 FREE end_of_the_skype_highlighting , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2